2-Phenylbenzo[D]Oxazole

2-Phenylbenzo[D]Oxazole

SCHEMBL29986166

[Ir+3].c1ccc(-c2nc3ccccc3o2)cc1.c1ccc(-c2nc3ccccc3o2)cc1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.70
RAB9A P51151 7/20 0.70
MEN1 O00255 4/20 0.70
KMT2A Q03164 4/20 0.70
ATM Q13315 1/20 0.70
HSD17B10 Q99714 6/20 0.66
ALDH1A1 P00352 5/20 0.66
HPGD P15428 6/20 0.64
SMN1; SMN2 Q16637 5/20 0.64
KDM4E B2RXH2 4/20 0.64
TP53 P04637 3/20 0.64
CASP3 P42574 2/20 0.61
SENP7 Q9BQF6 2/20 0.61
SENP6 Q9GZR1 2/20 0.61
POLB P06746 1/20 0.61
SENP8 Q96LD8 1/20 0.61
MMP2 P08253 1/20 0.60
MMP9 P14780 1/20 0.60
MMP8 P22894 1/20 0.60
MMP13 P45452 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Phenylbenzo[D]Oxazole SCHEMBL30022108 1.00 NPC1 (0.70) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL29819732 0.98 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL395084 0.98 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL29767802 0.98 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL2458370 0.98 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL127448 0.98 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL27567766 0.98 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL31738605 0.98 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL10670878 0.96 NPC1 (0.70) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL29083041 0.96 NPC1 (0.70) NPC1RAB9AMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240334814-A1 MIXED POWDER, MIXTURE, AND METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-10-03 US disclosed
WO-2023171544-A1 MIXED POWDER, METHOD FOR MANUFACTURING MIXED POWDER, COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT, AND METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT 出光興産株式会社 2023-09-14 WO disclosed
WO-2023100891-A1 SOLID MOLTEN MIXTURE, SOLID COMPOSITION, MIXED POWDER, METHOD FOR CHOOSING ORGANIC COMPOUND, METHOD FOR PRODUCING SOLID MOLTEN MIXTURE, AND METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT 出光興産株式会社 2023-06-08 WO disclosed
WO-2023063163-A1 MIXED POWDER FOR ORGANIC ELECTROLUMINESCENT ELEMENT, PRODUCTION METHOD THEREFOR, METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT USING SAID MIXED POWDER, METHOD FOR SELECTING COMPOUND IN SAID MIXED POWDER, AND COMPOSITION FOR VACUUM DEPOSITION 出光興産株式会社 2023-04-20 WO disclosed
US-20230001447-A1 MIXED POWDER, METHOD OF VAPOR-DEPOSITING ORGANIC COMPOUND, METHOD OF FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE, METHOD OF SELECTING ORGANIC COMPOUNDS, AND METHOD OF VAPOR-DEPOSITING IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-05 US disclosed
WO-2022270430-A1 MIXED POWDER, MIXTURE, AND METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT 出光興産株式会社 2022-12-29 WO disclosed
WO-2022270423-A1 MIXED POWDER FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR MANUFACTURING MIXED POWDER, METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT USING MIXED POWDER, METHOD FOR SELECTING COMPOUND IN MIXED POWDER, AND COMPOSITION FOR VACUUM DEPOSITION 出光興産株式会社 2022-12-29 WO disclosed
WO-2022270428-A1 MIXED POWDER FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR MANUFACTURING MIXED POWDER, METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT USING MIXED POWDER, METHOD FOR SELECTING COMPOUND IN MIXED POWDER, AND COMPOSITION FOR VACUUM DEPOSITION 出光興産株式会社 2022-12-29 WO disclosed
WO-2022244864-A1 MIXED POWDER, VAPOR DEPOSITION METHOD FOR ORGANIC COMPOUND, METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT, METHOD FOR SELECTING ORGANIC COMPOUND, AND VAPOR DEPOSITION METHOD 出光興産株式会社 2022-11-24 WO disclosed
US-11411182-B1 Mixed powder for organic electroluminescence device and method of producing the same, method of fabricating organic electroluminescence device using the mixed powder, method of selecting compounds for the mixed powder, and composition for vacuum vapor deposition IDEMITSU KOSAN CO., LTD. (JP) 2022-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240334814-A1 MIXED POWDER, MIXTURE, AND METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE EML4, ORC3, ZRANB2 NPC1 1535/4885RAB9A 2200/4885MEN1 552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.